What are the steps to manage a seizure code?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Seizure Code Management Protocol

For an active seizure lasting >5 minutes (status epilepticus), immediately administer benzodiazepines as first-line therapy, followed by second-line agents (fosphenytoin, levetiracetam, or valproic acid) if seizures persist, while simultaneously securing airway, establishing IV access, checking glucose, and identifying reversible causes. 1

Immediate Actions (First 0-5 Minutes)

Airway, Breathing, Circulation

  • Protect the airway and position patient to prevent aspiration (lateral decubitus if possible) 2
  • Administer supplemental oxygen and monitor oxygen saturation 3
  • Establish IV access immediately 3
  • Check fingerstick glucose immediately in all seizure patients, as hypoglycemia is a common reversible cause 4, 5

Initial Assessment During Seizure

  • Note seizure duration from onset (critical for determining status epilepticus) 1
  • Document seizure semiology: focal versus generalized onset 5
  • Monitor vital signs continuously 3

Pharmacologic Management Algorithm

First-Line Treatment (If Seizure >5 Minutes)

Administer benzodiazepines immediately: 1, 2

  • Lorazepam 0.1 mg/kg IV (preferred due to longer duration of action), OR
  • Diazepam 0.15-0.2 mg/kg IV 2

Second-Line Treatment (If Seizure Continues After Benzodiazepines)

Choose ONE of the following (all have similar 45-47% efficacy): 4, 1

  • Fosphenytoin: 18-20 mg PE/kg IV at 150 mg/min (preferred over phenytoin due to faster infusion rate and less hypotension risk) 1
  • Levetiracetam: 30 mg/kg IV at 5 mg/kg/min (no hypotension risk, efficacy 67-73%) 1
  • Valproate: 30 mg/kg IV at 6 mg/kg/hour (efficacy 68-88%, minimal hypotension) 1

Clinical Pearl: Phenytoin/fosphenytoin causes hypotension in 12% of cases versus 0% with valproate 1

Third-Line Treatment (Refractory Status Epilepticus)

If seizures persist after second-line agents: 1

  • Propofol: 1-2 mg/kg IV bolus, then 2-10 mg/kg/hour infusion, OR
  • Phenobarbital: 20 mg/kg IV at 50-100 mg/min 1
  • Consider ICU transfer and continuous EEG monitoring 1

Concurrent Diagnostic Workup

Identify and Correct Precipitating Factors

Search for reversible causes immediately: 6, 4, 1

Metabolic causes to check:

  • Hypoglycemia (check immediately) 4, 5
  • Hyponatremia (most common electrolyte cause) 4, 5
  • Hypocalcemia (can trigger seizures at any age) 4, 5
  • Hypomagnesemia (especially in alcohol-related seizures) 5
  • Uremia, hyperglycemia 5

Other acute causes:

  • Hypoxia 1
  • CNS infection (meningitis, encephalitis) 1, 5
  • Stroke or intracranial hemorrhage 1, 5
  • Medication non-compliance in known epilepsy patients 4
  • Toxic ingestions (tramadol, theophylline, isoniazid) 4, 7
  • Alcohol withdrawal 5, 7

Essential Laboratory Tests

  • Serum glucose (immediate) 4, 5
  • Complete metabolic panel: sodium, calcium, magnesium, renal function 4, 5
  • Consider toxicology screen if ingestion suspected 5

Post-Seizure Management

Neuroimaging Decisions

Obtain head CT in the emergency department for: 5

  • First-time seizure patients (34% have CT abnormalities) 5
  • Patients >60 years (highest yield) 5
  • Focal neurologic deficits present (81% have focal lesions, but 17% with normal exams still have abnormalities) 5
  • MRI is preferred when neuroimaging is obtained (higher sensitivity for structural lesions) 5

EEG Monitoring Indications

Consider emergent EEG for: 1

  • Persistent altered consciousness after seizure termination (rule out non-convulsive status epilepticus) 1
  • Patients who received long-acting paralytics 1
  • Patients in drug-induced coma 1

Disposition and Long-Term Management Decisions

When NOT to Start Antiepileptic Medications

Do not initiate long-term antiepileptics in the ED for: 6, 4

  • Provoked seizures (treat the underlying cause instead) 6, 4
  • Single unprovoked seizure without brain disease/injury (outpatient follow-up appropriate; NNT=14 to prevent one recurrence in 2 years) 6

When to CONSIDER Starting Antiepileptics

May initiate or defer to outpatient neurology for: 6

  • First unprovoked seizure WITH remote history of brain disease/injury (stroke, trauma, tumor) 6
  • These patients have higher recurrence risk and may benefit from treatment after single seizure 6

Admission Criteria

Patients do NOT require admission if: 6

  • First unprovoked seizure
  • Returned to clinical baseline in ED
  • No ongoing acute medical issues 6

Admit patients with:

  • Status epilepticus requiring multiple medications 1
  • Persistent altered mental status 1
  • Acute symptomatic causes requiring inpatient treatment 3
  • Refractory seizures 1

Critical Pitfalls to Avoid

  • Do not delay benzodiazepines if seizure exceeds 5 minutes—mortality increases significantly in refractory cases (65%) 1
  • Phenytoin is ineffective for alcohol withdrawal seizures and certain toxic ingestions (theophylline, isoniazid) 7
  • Do not assume epilepsy—most medically ill patients with secondary seizures do not have epilepsy; explain this to patients and families 7
  • Do not miss non-convulsive status epilepticus—consider in any patient with unexplained confusion or coma 1, 7
  • Do not start prophylactic anticonvulsants in stroke patients—may negatively affect neurological recovery 4

References

Guideline

Management of Status Epilepticus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prehospital management of the seizure patient.

Emergency medical services, 1999

Research

The evaluation and treatment of seizures in the emergency department.

The Mount Sinai journal of medicine, New York, 1997

Guideline

Seizure Precipitants and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Seizure Diagnosis and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Medical causes of seizures.

Lancet (London, England), 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.